Matthew J Carpenter1,2,3, Amy E Wahlquist2,3, Jennifer Dahne1,3, Kevin M Gray1,3, Elizabeth Garrett-Mayer2,3, K Michael Cummings1,2,3, Robert Davis4, Brent M Egan4. 1. Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA. 2. Department of Public Health Sciences,, Medical University of South Carolina, Charleston, SC, USA. 3. Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA. 4. Greenville Health System and Care Coordination Institute, Greenville, SC, USA.
Abstract
BACKGROUND AND AIMS: Within the context of busy clinical settings, health-care providers need practical, evidence-based options to engage smokers in quitting. Sampling of nicotine replacement therapy [i.e. provision of nicotine replacement therapy (NRT starter kits)] is a brief, pragmatic strategy to address this need. We aimed to compare the effects of NRT sampling plus standard care (SC), relative to SC alone, provided by primary care providers during routine clinic visits. DESIGN: Cluster-randomized clinical trial. SETTING:Twenty-two primary care clinics in South Carolina, USA. PARTICIPANTS: Adult smokers [n = 1245; 61% female, mean age = 50.7, standard deviation (SD) = 13.5] both motivated and unmotivated to quit, seen during routine clinical visit. Interventions were provider-delivered SC (n = 652, 12 clinics) cessation advice or SC + a 2-week supply of both nicotine patch and lozenge, with minimal instructions on use (n = 593; 10 clinics). MEASUREMENTS: The primary outcome was 7-day point prevalence smoking abstinence at 6-month follow-up, using intent-to-treat. Additional outcomes included NRT use and quit attempts, assessed at 1, 3 and 6 months following baseline. FINDINGS: Seven-day point prevalence abstinence rates were significantly higher in the NRT sampling group throughout follow-up, including at 6 months [12 versus 8%, odds ratio (OR) = 1.5, 95% confidence interval (CI) = 1.0-2.4]. NRT sampling increased prevalence of any use of NRT (65 versus 25%, OR = 5.8, 95% CI = 4.3-7.7), with higher prevalence of use at 6 months (25 versus 14%, OR = 2.0, 95% CI = 1.5-2.7). NRT sampling increased the rate of quit attempts in the initial month (24 versus 18%, OR = 1.5, 95% CI = 1.0-2.3) but had no significant effect on overall rate of quit attempts (48 versus 45%, OR = 1.2, 95% CI = 0.8-1.7). CONCLUSION: Providing smokers with a free 2-week starter kit of nicotine replacement therapy increased quit attempts, use of stop smoking medications and smoking abstinence compared with standard care in a primary care setting.
RCT Entities:
BACKGROUND AND AIMS: Within the context of busy clinical settings, health-care providers need practical, evidence-based options to engage smokers in quitting. Sampling of nicotine replacement therapy [i.e. provision of nicotine replacement therapy (NRT starter kits)] is a brief, pragmatic strategy to address this need. We aimed to compare the effects of NRT sampling plus standard care (SC), relative to SC alone, provided by primary care providers during routine clinic visits. DESIGN: Cluster-randomized clinical trial. SETTING: Twenty-two primary care clinics in South Carolina, USA. PARTICIPANTS: Adult smokers [n = 1245; 61% female, mean age = 50.7, standard deviation (SD) = 13.5] both motivated and unmotivated to quit, seen during routine clinical visit. Interventions were provider-delivered SC (n = 652, 12 clinics) cessation advice or SC + a 2-week supply of both nicotine patch and lozenge, with minimal instructions on use (n = 593; 10 clinics). MEASUREMENTS: The primary outcome was 7-day point prevalence smoking abstinence at 6-month follow-up, using intent-to-treat. Additional outcomes included NRT use and quit attempts, assessed at 1, 3 and 6 months following baseline. FINDINGS: Seven-day point prevalence abstinence rates were significantly higher in the NRT sampling group throughout follow-up, including at 6 months [12 versus 8%, odds ratio (OR) = 1.5, 95% confidence interval (CI) = 1.0-2.4]. NRT sampling increased prevalence of any use of NRT (65 versus 25%, OR = 5.8, 95% CI = 4.3-7.7), with higher prevalence of use at 6 months (25 versus 14%, OR = 2.0, 95% CI = 1.5-2.7). NRT sampling increased the rate of quit attempts in the initial month (24 versus 18%, OR = 1.5, 95% CI = 1.0-2.3) but had no significant effect on overall rate of quit attempts (48 versus 45%, OR = 1.2, 95% CI = 0.8-1.7). CONCLUSION: Providing smokers with a free 2-week starter kit of nicotine replacement therapy increased quit attempts, use of stop smoking medications and smoking abstinence compared with standard care in a primary care setting.
Authors: K Michael Cummings; Brian Fix; Paula Celestino; Shannon Carlin-Menter; Richard O'Connor; Andrew Hyland Journal: J Public Health Manag Pract Date: 2006 Jan-Feb
Authors: Bianca F Jardin; Karen L Cropsey; Amy E Wahlquist; Kevin M Gray; Gerard A Silvestri; K Michael Cummings; Matthew J Carpenter Journal: Nicotine Tob Res Date: 2014-03-07 Impact factor: 4.244
Authors: Matthew J Carpenter; John R Hughes; Kevin M Gray; Amy E Wahlquist; Michael E Saladin; Anthony J Alberg Journal: Arch Intern Med Date: 2011-11-28
Authors: Karin A Kasza; Andrew J Hyland; Ron Borland; Ann D McNeill; Maansi Bansal-Travers; Brian V Fix; David Hammond; Geoffrey T Fong; K Michael Cummings Journal: Addiction Date: 2012-08-14 Impact factor: 6.526
Authors: K Michael Cummings; Andrew Hyland; Shannon Carlin-Menter; Martin C Mahoney; Jeffrey Willett; Harlan R Juster Journal: J Public Health Manag Pract Date: 2011 May-Jun
Authors: Brian V Fix; Andrew Hyland; Cheryl Rivard; Ann McNeill; Geoffrey T Fong; Ron Borland; David Hammond; K Michael Cummings Journal: Int J Environ Res Public Health Date: 2011-01-20 Impact factor: 3.390
Authors: Brian Chen; Gerard A Silvestri; Jennifer Dahne; Kyueun Lee; Matthew J Carpenter Journal: J Gen Intern Med Date: 2022-01-28 Impact factor: 6.473
Authors: Chelsea M Cox; Jennifer C Westrick; Danielle E McCarthy; Matthew J Carpenter; Amanda R Mathew Journal: J Stud Alcohol Drugs Date: 2022-01 Impact factor: 2.582
Authors: Christine Vinci; Cho Lam; Chelsey R Schlechter; Yusuke Shono; Jennifer I Vidrine; David W Wetter Journal: Transl Behav Med Date: 2022-01-18 Impact factor: 3.626
Authors: Krysten W Bold; Sydney Cannon; Bennie B Ford; Susan Neveu; Polly Sather; Benjamin A Toll; Lisa M Fucito Journal: Cancer Prev Res (Phila) Date: 2022-05-03
Authors: Matthew J Carpenter; Kevin M Gray; Amy E Wahlquist; Karen Cropsey; Michael E Saladin; Brett Froeliger; Tracy T Smith; Benjamin A Toll; Jennifer Dahne Journal: Nicotine Tob Res Date: 2021-05-24 Impact factor: 4.244
Authors: Jennifer Dahne; Rachel L Tomko; Erin A McClure; Jihad S Obeid; Matthew J Carpenter Journal: Nicotine Tob Res Date: 2020-12-12 Impact factor: 4.244